Additional Proxy Soliciting Materials (definitive) (defa14a)
26 Abril 2023 - 3:39PM
Edgar (US Regulatory)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
|
Filed by the Registrant ☒
|
|
|
Filed by a Party other than the Registrant ☐
|
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement
|
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
| ☐ |
Definitive Proxy Statement
|
| ☒ |
Definitive Additional Materials
|
| ☐ |
Soliciting Material Pursuant to § 240.14a-12
|
EIGER BIOPHARMACEUTICALS, INC.
(Name of Registrant as Specified in Its Charter)
Not Applicable.
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check all boxes that apply)
| ☒ |
No fee required.
|
| ☐ |
Fee paid previously with preliminary materials.
|
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
Eiger BioPharmaceuticals (NASDAQ:EIGR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Eiger BioPharmaceuticals (NASDAQ:EIGR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
